−0.025 CAD
−262.47 K CAD
0.00 CAD
9.75 M
About BIOCURE TECHNOLOGY INC.
Sector
Industry
CEO
Yee Sing Cheng
Website
Headquarters
Vancouver
Founded
2007
FIGI
BBG000QW95B7
Biocure Technology, Inc. engages in the development and commercialization of biosimilar products. Its also offers CAR-T Cell immunotherapy, hair growth treatment, and FMD vaccine products. The company was founded on August 24, 2007 and is headquartered in Vancouver, Canada.
Related stocks
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of CURE.X is 0.050 CAD — it hasn't changed in the past 24 hours. Watch BIOCURE TECHNOLOGY INC. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on CSE exchange BIOCURE TECHNOLOGY INC. stocks are traded under the ticker CURE.X.
CURE.X reached its all-time high on Feb 1, 2018 with the price of 17.010 CAD, and its all-time low was 0.010 CAD and was reached on Nov 27, 2024. View more price dynamics on CURE.X chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
CURE.X stock is 0.00% volatile and has beta coefficient of 3.91. Track BIOCURE TECHNOLOGY INC. stock price on the chart and check out the list of the most volatile stocks — is BIOCURE TECHNOLOGY INC. there?
Yes, you can track BIOCURE TECHNOLOGY INC. financials in yearly and quarterly reports right on TradingView.
CURE.X net income for the last quarter is −6.29 K CAD, while the quarter before that showed −209.68 K CAD of net income which accounts for 97.00% change. Track more BIOCURE TECHNOLOGY INC. financial stats to get the full picture.
No, CURE.X doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CURE.X shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIOCURE TECHNOLOGY INC. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BIOCURE TECHNOLOGY INC. technincal analysis shows the neutral today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BIOCURE TECHNOLOGY INC. stock shows the sell signal. See more of BIOCURE TECHNOLOGY INC. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.